
News|Articles|November 27, 2023
The value of Innovative Medicine: The clinical and economic impact of the first gene therapy for hemophilia B
Advertisement
Content provided by CSL Behring. Copyright 2023 and published by MJH Life Sciences®. No portion of this program may be reproduced or transmitted in any form, by any means, without the prior written permission of MJH Life Sciences. The views and opinions expressed in this material do not necessarily reflect the views and opinions of MJH Life Sciences, or Managed Healthcare Executive®.
Advertorial:
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The FDA proposes ditching comparative efficacy studies for biosimilars
2
UC Davis develops new drug for bladder cancer patients
3
Phase 3 trial launches for novel antibody targeting integrin beta-6 in advanced lung cancer
4
NIH’s investigational AI technology unlocks faster, clearer retinal imaging with 75% less data
5















































